SCHEMBL30132230

SCHEMBL30132230

CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.78

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 8/20 0.70
▸ NTSR1 P30989 3/20 0.65
▸ OPRM1 P35372 1/20 0.65
▸ OPRK1 P41145 1/20 0.65
▸ NTSR2 O95665 1/20 0.64
▸ NPY1R P25929 1/20 0.63
▸ F2 P00734 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dynorphin A (1-11) SCHEMBL30132402 0.88 OPRD1 (0.86) OPRD1NTSR1OPRM1OPRK1NTSR2
Analog Of Dynorphin A SCHEMBL29389694 0.88 OPRD1 (0.86) OPRD1NTSR1OPRM1OPRK1NTSR2
SCHEMBL30741227 0.87 OPRD1 (0.69) OPRD1NTSR1OPRM1OPRK1F2
SCHEMBL31182878 0.87 CALCR (0.70) OPRD1OPRM1OPRK1NPY1R
SCHEMBL29716758 0.87 CXCR4 (0.60) OPRD1NPY1R
SCHEMBL29878209 0.87 OPRD1 (0.85) OPRD1NTSR1OPRM1OPRK1NTSR2
SCHEMBL30218808 0.86 CALCR (0.62) OPRD1NTSR1NTSR2F2
SCHEMBL30435444 0.86 OPRD1 (0.67) OPRD1OPRM1OPRK1NPY1R
SCHEMBL31009049 0.86 OPRD1 (0.88) OPRD1NTSR1OPRM1OPRK1NTSR2
SCHEMBL29648931 0.86 OPRD1 (0.90) OPRD1NTSR1OPRM1OPRK1NTSR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295281-A1 NATURAL ANTIBODIES IN PROPHYLAXIS AND THERAPY Vanudis GmbH (DE) 2023-09-21 — — US disclosed
EP-4132573-A1 NATURAL ANTIBODIES IN PROPHYLAXIS AND THERAPY Vanudis GmbH (DE) 2023-02-15 — — EP disclosed
CN-115697395-A Natural antibodies in prophylaxis and therapy 瓦努迪斯有限公司 2023-02-03 — — CN disclosed
Send feedback